IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v11y2020i1d10.1038_s41467-019-13825-8.html
   My bibliography  Save this article

A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns

Author

Listed:
  • Wei Jiao

    (Ontario Institute for Cancer Research)

  • Gurnit Atwal

    (Ontario Institute for Cancer Research
    University of Toronto
    Vector Institute)

  • Paz Polak

    (Broad Institute of MIT and Harvard
    Harvard Medical School
    Massachusetts General Hospital
    Icahn School of Medicine at Mount Sinai)

  • Rosa Karlic

    (University of Zagreb)

  • Edwin Cuppen

    (Hartwig Medical Foundation
    University Medical Center Utrecht)

  • Alexandra Danyi

    (University Medical Center Utrecht)

  • Jeroen Ridder

    (University Medical Center Utrecht)

  • Carla Herpen

    (Radboud University Medical Center)

  • Martijn P. Lolkema

    (University Medical Center Rotterdam)

  • Neeltje Steeghs

    (The Netherlands Cancer Institute)

  • Gad Getz

    (Broad Institute of MIT and Harvard
    Harvard Medical School
    Massachusetts General Hospital
    Massachusetts General Hospital)

  • Quaid D. Morris

    (Vector Institute
    University of Toronto)

  • Lincoln D. Stein

    (Ontario Institute for Cancer Research
    University of Toronto)

Abstract

In cancer, the primary tumour’s organ of origin and histopathology are the strongest determinants of its clinical behaviour, but in 3% of cases a patient presents with a metastatic tumour and no obvious primary. Here, as part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, we train a deep learning classifier to predict cancer type based on patterns of somatic passenger mutations detected in whole genome sequencing (WGS) of 2606 tumours representing 24 common cancer types produced by the PCAWG Consortium. Our classifier achieves an accuracy of 91% on held-out tumor samples and 88% and 83% respectively on independent primary and metastatic samples, roughly double the accuracy of trained pathologists when presented with a metastatic tumour without knowledge of the primary. Surprisingly, adding information on driver mutations reduced accuracy. Our results have clinical applicability, underscore how patterns of somatic passenger mutations encode the state of the cell of origin, and can inform future strategies to detect the source of circulating tumour DNA.

Suggested Citation

  • Wei Jiao & Gurnit Atwal & Paz Polak & Rosa Karlic & Edwin Cuppen & Alexandra Danyi & Jeroen Ridder & Carla Herpen & Martijn P. Lolkema & Neeltje Steeghs & Gad Getz & Quaid D. Morris & Lincoln D. Stein, 2020. "A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns," Nature Communications, Nature, vol. 11(1), pages 1-12, December.
  • Handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-019-13825-8
    DOI: 10.1038/s41467-019-13825-8
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-019-13825-8
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-019-13825-8?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Lina Zheng & Wei Wang, 2022. "Regulation associated modules reflect 3D genome modularity associated with chromatin activity," Nature Communications, Nature, vol. 13(1), pages 1-11, December.
    2. Mingyun Bae & Gyuhee Kim & Tae-Rim Lee & Jin Mo Ahn & Hyunwook Park & Sook Ryun Park & Ki Byung Song & Eunsung Jun & Dongryul Oh & Jeong-Won Lee & Young Sik Park & Ki-Won Song & Jeong-Sik Byeon & Bo H, 2023. "Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
    3. Shirong Zhang & Shutao He & Xin Zhu & Yunfei Wang & Qionghuan Xie & Xianrang Song & Chunwei Xu & Wenxian Wang & Ligang Xing & Chengqing Xia & Qian Wang & Wenfeng Li & Xiaochen Zhang & Jinming Yu & She, 2023. "DNA methylation profiling to determine the primary sites of metastatic cancers using formalin-fixed paraffin-embedded tissues," Nature Communications, Nature, vol. 14(1), pages 1-11, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-019-13825-8. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.